RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 107 filers reported holding RIGEL PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,783,985 | -16.8% | 3,503,690 | -0.6% | 0.00% | – |
| Q2 2023 | $4,546,237 | -0.1% | 3,524,215 | +2.3% | 0.00% | – |
| Q1 2023 | $4,548,925 | -55.1% | 3,446,155 | -48.9% | 0.00% | – |
| Q4 2022 | $10,124,742 | +121.3% | 6,749,828 | +74.1% | 0.00% | – |
| Q3 2022 | $4,576,000 | -83.1% | 3,878,066 | -83.8% | 0.00% | -100.0% |
| Q2 2022 | $27,058,000 | +20.3% | 23,945,568 | +218.2% | 0.00% | +100.0% |
| Q1 2022 | $22,497,000 | -0.9% | 7,524,206 | -12.2% | 0.00% | 0.0% |
| Q4 2021 | $22,699,000 | -28.1% | 8,565,810 | -1.5% | 0.00% | -50.0% |
| Q3 2021 | $31,575,000 | -32.0% | 8,698,439 | -18.6% | 0.00% | 0.0% |
| Q2 2021 | $46,403,000 | +8.4% | 10,691,924 | -14.6% | 0.00% | 0.0% |
| Q1 2021 | $42,807,000 | +30.6% | 12,516,725 | +33.7% | 0.00% | 0.0% |
| Q4 2020 | $32,769,000 | +35.1% | 9,362,504 | -7.4% | 0.00% | 0.0% |
| Q3 2020 | $24,255,000 | +271.9% | 10,106,345 | +183.6% | 0.00% | – |
| Q2 2020 | $6,522,000 | +17.8% | 3,563,702 | +0.4% | 0.00% | – |
| Q1 2020 | $5,537,000 | -29.6% | 3,549,638 | -3.5% | 0.00% | -100.0% |
| Q4 2019 | $7,868,000 | +23.6% | 3,676,582 | +8.0% | 0.00% | – |
| Q3 2019 | $6,367,000 | -64.1% | 3,404,639 | -49.8% | 0.00% | -100.0% |
| Q2 2019 | $17,718,000 | -13.1% | 6,788,447 | -14.5% | 0.00% | -50.0% |
| Q1 2019 | $20,397,000 | +16.7% | 7,936,667 | +4.4% | 0.00% | 0.0% |
| Q4 2018 | $17,485,000 | -24.4% | 7,602,003 | +5.5% | 0.00% | 0.0% |
| Q3 2018 | $23,128,000 | +2.2% | 7,204,491 | -9.9% | 0.00% | 0.0% |
| Q2 2018 | $22,629,000 | +27.9% | 7,995,273 | +60.0% | 0.00% | 0.0% |
| Q1 2018 | $17,699,000 | +14.4% | 4,998,409 | +25.3% | 0.00% | +100.0% |
| Q4 2017 | $15,473,000 | +170.5% | 3,988,557 | +77.0% | 0.00% | – |
| Q3 2017 | $5,721,000 | -4.2% | 2,252,930 | +2.9% | 0.00% | -100.0% |
| Q2 2017 | $5,974,000 | -14.0% | 2,188,997 | +4.3% | 0.00% | 0.0% |
| Q1 2017 | $6,947,000 | +70.7% | 2,098,357 | +22.5% | 0.00% | – |
| Q4 2016 | $4,070,000 | -30.7% | 1,712,369 | +7.1% | 0.00% | -100.0% |
| Q3 2016 | $5,869,000 | +65.6% | 1,599,573 | +0.7% | 0.00% | – |
| Q2 2016 | $3,544,000 | +15.3% | 1,588,902 | +7.4% | 0.00% | – |
| Q1 2016 | $3,075,000 | -29.5% | 1,479,088 | +2.7% | 0.00% | – |
| Q4 2015 | $4,359,000 | +22.7% | 1,440,352 | +0.2% | 0.00% | – |
| Q3 2015 | $3,553,000 | -24.2% | 1,437,293 | -1.5% | 0.00% | -100.0% |
| Q2 2015 | $4,688,000 | -11.0% | 1,459,379 | -1.1% | 0.00% | 0.0% |
| Q1 2015 | $5,267,000 | +61.2% | 1,475,061 | +2.6% | 0.00% | – |
| Q4 2014 | $3,267,000 | +12.7% | 1,438,116 | -3.9% | 0.00% | – |
| Q3 2014 | $2,900,000 | -44.8% | 1,496,565 | +3.4% | 0.00% | -100.0% |
| Q2 2014 | $5,257,000 | -9.7% | 1,447,992 | -3.5% | 0.00% | 0.0% |
| Q1 2014 | $5,820,000 | -69.2% | 1,500,376 | -59.8% | 0.00% | 0.0% |
| Q4 2013 | $18,918,000 | +263.8% | 3,734,419 | +157.1% | 0.00% | 0.0% |
| Q3 2013 | $5,200,000 | -60.1% | 1,452,248 | -62.8% | 0.00% | -50.0% |
| Q2 2013 | $13,027,000 | – | 3,900,675 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 8,350,000 | $28,557,000 | 5.86% |
| Ion Asset Management Ltd. | 3,632,132 | $12,422,000 | 1.43% |
| CM Management, LLC | 500,000 | $1,710,000 | 1.27% |
| SECTOR GAMMA AS | 1,530,490 | $5,234,000 | 0.96% |
| Rhenman & Partners Asset Management AB | 1,520,000 | $5,198,000 | 0.36% |
| Rock Springs Capital Management LP | 4,742,000 | $16,218,000 | 0.35% |
| Telemetry Investments, L.L.C. | 90,000 | $308,000 | 0.35% |
| DAFNA Capital Management LLC | 275,500 | $942,000 | 0.22% |
| KELLEHER FINANCIAL ADVISORS | 100,000 | $342,000 | 0.22% |
| Virtus ETF Advisers LLC | 91,971 | $315,000 | 0.13% |